Extracellular vesicles derived from radioresistant oral squamous cell carcinoma cells contribute to the acquisition of radioresistance via the miR‐503‐3p‐BAK axisK. Yamana, Hideki Nakayama, Akiyuki Hirosue et al.|Journal of Extracellular Vesicles|2021Cited by 44
FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma CellsHisashi Takeshita, Hideki Nakayama, Ryoji Yoshida et al.|Laboratory Investigation|2023Cited by 16
FOXP3 lymphocyte status may predict the risk of malignant transformation in oral leukoplakiaJunki Sakata, Hideki Nakayama, Ryoji Yoshida et al.|Journal of Oral and Maxillofacial Surgery Medicine and Pathology|2019Cited by 12
An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinomaShunsuke Gohara, Hideki Nakayama, Kosuke Shinohara et al.|Molecular Therapy — Oncolytics|2022Cited by 11
Role of serum amylase and salivary cytokines in oral complications during chemoradiotherapyKenta Kawahara, Hideki Nakayama, Akimitsu Hiraki et al.|Oral Diseases|2020Cited by 6